Rise in Peptide Synthesis Services in India is Escalating Indian Peptide Therapeutics Market

Published: Nov 2020

Indian peptide therapeutics market will see a considerable growth of 7.6% during the forecast period. India is one of the potential markets for peptide therapeutics particularly due to a high prevalence of cancer and large mortality due to cancer and CVDs. 

India is providing new growth opportunities for the peptide therapeutics market expansion in the generic peptide drug and API market. Moreover, custom peptide synthesis services are gaining huge traction in India. Several local healthcare companies are offering custom peptide synthesis services. USV Pvt. Ltd., TCI Chemicals (India) Pvt. Ltd., Biotech Desk Pvt Ltd., Life Technologies (India) Pvt Ltd., GenPro Biotech are some of the players in the Indian peptide therapeutics market, offering custom peptide synthesis services.

Browse the full report description of "Indian Peptide Therapeutics Market Size, Share & Trends Analysis Report, By Route of Administration (Oral and Parenteral), by Application (Cancer, Metabolic Disorder, Gastrointestinal Disorders, Central Nervous System Disorders, Respiratory Disorders, and Others), Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/indian-peptide-therapeutics-market

The companies are offering their custom peptide synthesis services to the biomedical research community, biotechnology, and pharmaceutical industry. Along with the companies, the National Institute for Research in Reproductive Health (NIRRH), has a dedicated resource for the chemical synthesis of peptides of required amino acid sequences. 

The users are expected to offer the sequence of the peptides (up to 20 residues max) that are required to be synthesized. The purified synthetic peptides are offered in dried form along with the RP-HPLC profiles, MALDI-TOF spectra, and amino acid composition of the synthesized peptide. Therefore, combinedly, the research institutes and market players are driving the peptide synthesis services in India, which in turn, is escalating the India peptide therapeutics market.

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Route of Administration and By Application

Key Companies Profiled

AstraZeneca Plc, Teva Pharmaceuticals Co. Ltd., Flagship Biotech International Pvt. Ltd., and Hemmo Pharmaceuticals Pvt. Ltd.


Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market during the forecast period?
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

India Peptide Therapeutics Market – Segmentation

By Route of Administration

  • Oral
  • Parenteral

By Application

  • Cancer
  • Metabolic Disorder
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Respiratory Disorders
  • Others (Kidney Disorder and Autoimmune Disorder)

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/indian-peptide-therapeutics-market